Rural Health
Resources by Topic: Pharmacy and prescription drugs
Beneficiary and Clinician Perspectives on Medicare and Other Issues: Findings from 2025 Focus Groups in St. Louis, Missouri, and 2021–2025 Rural Focus Groups
Summarizes findings from 8 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between April and May 2025, including one virtual focus group of rural Medicare beneficiaries. Compiles findings from 13 focus groups of rural Medicare beneficiaries between 2021 and 2025. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 06/2025
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details
Summarizes findings from 8 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between April and May 2025, including one virtual focus group of rural Medicare beneficiaries. Compiles findings from 13 focus groups of rural Medicare beneficiaries between 2021 and 2025. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 06/2025
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details
MedPAC Report to the Congress: Medicare and the Health Care Delivery System, June 2025
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Covers proposed reforms to the physician fee schedule updates and the accuracy of relative payment rates; supplemental benefits in Medicare Advantage; home healthcare use among Medicare Advantage enrollees; Part D prescription drug plans for beneficiaries in fee-for-service Medicare and Medicare Advantage; Medicare beneficiaries in nursing homes; the inclusion of rural providers in current Medicare fee-for-service quality reporting programs; and recommendations related to reducing beneficiary cost sharing for outpatient services at Critical Access Hospitals. Includes rural references throughout.
Additional links: Executive Summary
Date: 06/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Covers proposed reforms to the physician fee schedule updates and the accuracy of relative payment rates; supplemental benefits in Medicare Advantage; home healthcare use among Medicare Advantage enrollees; Part D prescription drug plans for beneficiaries in fee-for-service Medicare and Medicare Advantage; Medicare beneficiaries in nursing homes; the inclusion of rural providers in current Medicare fee-for-service quality reporting programs; and recommendations related to reducing beneficiary cost sharing for outpatient services at Critical Access Hospitals. Includes rural references throughout.
Additional links: Executive Summary
Date: 06/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Report to Congress on Medicaid and CHIP, June 2025
Semi-annual report to Congress from the Medicaid and CHIP Payment and Access Commission (MACPAC). Covers recommendations related to transitions from pediatric to adult care for Medicaid-covered children and youth with special health care needs (CYSHCN). Also discusses appropriate access to residential behavioral health treatment services for children, findings from MACPAC's analytic work on access to medications for opioid use disorder (MOUD) in Medicaid, an overview on the Program of All-Inclusive Care for the Elderly, and self-direction for Medicaid home- and community-based services. Includes rural references throughout.
Date: 06/2025
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Semi-annual report to Congress from the Medicaid and CHIP Payment and Access Commission (MACPAC). Covers recommendations related to transitions from pediatric to adult care for Medicaid-covered children and youth with special health care needs (CYSHCN). Also discusses appropriate access to residential behavioral health treatment services for children, findings from MACPAC's analytic work on access to medications for opioid use disorder (MOUD) in Medicaid, an overview on the Program of All-Inclusive Care for the Elderly, and self-direction for Medicaid home- and community-based services. Includes rural references throughout.
Date: 06/2025
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Pharmacy Deserts in Rural Pennsylvania
Describes the landscape of pharmacies and pharmacists in Pennsylvania as of May 2025 and examines the projected impact of Rite Aid pharmacy closures. Features statistics on numbers of pharmacies and pharmacists, with breakdowns by urban and rural areas, and county-level maps showing areas within a 5-mile radius of all pharmacies and all non-Rite Aid pharmacies, with shadings showing urban and rural areas.
Date: 06/2025
Sponsoring organization: Center for Rural Pennsylvania
view details
Describes the landscape of pharmacies and pharmacists in Pennsylvania as of May 2025 and examines the projected impact of Rite Aid pharmacy closures. Features statistics on numbers of pharmacies and pharmacists, with breakdowns by urban and rural areas, and county-level maps showing areas within a 5-mile radius of all pharmacies and all non-Rite Aid pharmacies, with shadings showing urban and rural areas.
Date: 06/2025
Sponsoring organization: Center for Rural Pennsylvania
view details
Practical Ways to Implement The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain among American Indian and Alaska Native Patients
Report presents strategies for adapting the Centers for Disease Control and Prevention's 2022 opioid prescribing guidelines for application in American Indian and Alaska Native (AI/AN) communities. Discusses methods for clinicians to speak with AI/AN patients about pain and the options available to them.
Author(s): Myra Parker, Kase Cragg, Jacob Fong-Gurzinsky, et al.
Date: 05/2025
Sponsoring organization: Seven Directions - A Center for Indigenous Public Health
view details
Report presents strategies for adapting the Centers for Disease Control and Prevention's 2022 opioid prescribing guidelines for application in American Indian and Alaska Native (AI/AN) communities. Discusses methods for clinicians to speak with AI/AN patients about pain and the options available to them.
Author(s): Myra Parker, Kase Cragg, Jacob Fong-Gurzinsky, et al.
Date: 05/2025
Sponsoring organization: Seven Directions - A Center for Indigenous Public Health
view details
Wait Times for Medical Appointments among Adults Age 50 and Older
Reports on wait times and distance to healthcare services in rural and urban communities, utilizing data from a February 2025 survey of 1,012 adults age 50 or older. Breaks down data by level of rurality, type of facility, and type of care provided.
Additional links: Annotated Questionnaire
Author(s): Teresa A. Keenan
Date: 05/2025
Sponsoring organization: AARP
view details
Reports on wait times and distance to healthcare services in rural and urban communities, utilizing data from a February 2025 survey of 1,012 adults age 50 or older. Breaks down data by level of rurality, type of facility, and type of care provided.
Additional links: Annotated Questionnaire
Author(s): Teresa A. Keenan
Date: 05/2025
Sponsoring organization: AARP
view details
Congress Must Act to Bring Needed Reforms to the 340B Drug Pricing Program: Majority Staff Report
Presents findings from a U.S. Senate Committee on Health, Education, Labor & Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout.
Date: 04/2025
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents findings from a U.S. Senate Committee on Health, Education, Labor & Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout.
Date: 04/2025
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Stand-Alone Drug Plans Cover a Larger Share of Medicare Part D Enrollees Living in the Most Rural Areas Than Medicare Advantage Plans
Examines Medicare Part D enrollment in stand-alone Medicare prescription drug plans and Medicare Advantage drug plans in 2025. Presents data by urban, rural adjacent, and rural non-adjacent status nationally and by state.
Author(s): Juliette Cubanski, Tricia Neuman, Anthony Damico
Date: 04/2025
Sponsoring organization: KFF
view details
Examines Medicare Part D enrollment in stand-alone Medicare prescription drug plans and Medicare Advantage drug plans in 2025. Presents data by urban, rural adjacent, and rural non-adjacent status nationally and by state.
Author(s): Juliette Cubanski, Tricia Neuman, Anthony Damico
Date: 04/2025
Sponsoring organization: KFF
view details
Characteristics of Adults Age 18 and Older Who Took Prescription Medication for Depression: United States, 2023
Provides 2023 data on the characteristics of adults who took prescription medication for depression. Includes a breakdown by region and urbanization level, including nonmetropolitan, medium and small metropolitan, large fringe metropolitan, or large central metropolitan area.
Author(s): Nazik Elgaddal, Julie D. Weeks, Laryssa Mykyta
Date: 04/2025
Sponsoring organization: National Center for Health Statistics
view details
Provides 2023 data on the characteristics of adults who took prescription medication for depression. Includes a breakdown by region and urbanization level, including nonmetropolitan, medium and small metropolitan, large fringe metropolitan, or large central metropolitan area.
Author(s): Nazik Elgaddal, Julie D. Weeks, Laryssa Mykyta
Date: 04/2025
Sponsoring organization: National Center for Health Statistics
view details
April 2025 MedPAC Meeting Transcript
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2025 meeting. Covers physician fee schedule updates and improving the accuracy of relative payment rates; structural differences between the stand-alone prescription drug plan (PDP) and Medicare Advantage–Prescription Drug plan (MA–PD) markets; the utilization and delivery of Medicare Advantage supplemental benefits; the effect of Medicare Advantage on rural hospitals; paying for software technologies in Medicare; access to hospice and certain services under the hospice benefit for beneficiaries with end-stage renal disease and beneficiaries with cancer; and regulations, star ratings, and fee-for-service Medicare policies aimed at improving nursing home quality.
Additional links: Exploring the Effect of Medicare Advantage on Rural Hospitals
Date: 04/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2025 meeting. Covers physician fee schedule updates and improving the accuracy of relative payment rates; structural differences between the stand-alone prescription drug plan (PDP) and Medicare Advantage–Prescription Drug plan (MA–PD) markets; the utilization and delivery of Medicare Advantage supplemental benefits; the effect of Medicare Advantage on rural hospitals; paying for software technologies in Medicare; access to hospice and certain services under the hospice benefit for beneficiaries with end-stage renal disease and beneficiaries with cancer; and regulations, star ratings, and fee-for-service Medicare policies aimed at improving nursing home quality.
Additional links: Exploring the Effect of Medicare Advantage on Rural Hospitals
Date: 04/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details